Researchers have discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly ...

The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...

The following is a summary of “Can self-testing be enhanced to hasten safe return of healthcare workers in pandemics? Random ...

Grant documents that detailed creating the virus that causes COVID-19 may have been concealed, leading to a “flawed” probe of ...

"Very high" levels of the virus were detected by the CDC in New Mexico, with "high" levels in Oregon, Arkansas, and Maine.

Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with $106.9 million in cash and cash equivalentsTargets ...

The world's first self-amplifying mRNA vaccine, or replicon vaccine, was administered in Japan to prevent SARS-CoV-2 infection.1 Similar to other infodemics related to COVID-19 vaccines,2 ...

Researchers at Kumamoto University have made a significant breakthrough in the fight against COVID-19 with the development of ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Researchers discovered that SARS-CoV-2 hijacks three important host proteins that dampen the complement system's activity.